Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
233,192,423
-
Share change
-
+6,166,990
-
Total reported value
-
$26,189,310,928
-
Put/Call ratio
-
143%
-
Price per share
-
$112.31
-
Number of holders
-
421
-
Value change
-
+$763,833,066
-
Number of buys
-
216
-
Number of sells
-
172
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2014
As of 30 Sep 2014,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
421 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
233,192,423 shares.
The largest 10 holders included
Capital World Investors, WELLINGTON MANAGEMENT CO LLP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, State Street Corp, Ameriprise Financial Inc, and Clearbridge Investments, LLC.
This page lists
421
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.